Toxin yet not toxic: Botulinum toxin in dentistry

Saudi Dent J. 2016 Apr;28(2):63-9. doi: 10.1016/j.sdentj.2015.08.002. Epub 2015 Dec 21.

Abstract

Paracelsus contrasted poisons from nonpoisons, stating that "All things are poisons, and there is nothing that is harmless; the dose alone decides that something is a poison". Living organisms, such as plants, animals, and microorganisms, constitute a huge source of pharmaceutically useful medicines and toxins. Depending on their source, toxins can be categorized as phytotoxins, mycotoxins, or zootoxins, which include venoms and bacterial toxins. Any toxin can be harmful or beneficial. Within the last 100 years, the perception of botulinum neurotoxin (BTX) has evolved from that of a poison to a versatile clinical agent with various uses. BTX plays a key role in the management of many orofacial and dental disorders. Its indications are rapidly expanding, with ongoing trials for further applications. However, despite its clinical use, what BTX specifically does in each condition is still not clear. The main aim of this review is to describe some of the unclear aspects of this potentially useful agent, with a focus on the current research in dentistry.

Keywords: Acetylcholine; BTX, botulinum neurotoxin; EMG, electromyography; MPDS, myofacial pain dysfunction syndrome; Neurotoxin; Neurotransmitters; Oro-facial disorders; SNAP-25, synaptosomal-associated protein; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; TGF-β1, transforming growth factor β-1.

Publication types

  • Review